Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards SRI, UCSF $10M to Study PGx of Nicotine Addiction

NEW YORK, Jan. 25 (GenomeWeb News) - The National Institutes of Health has awarded a five-year, $10 million grant to the University of California, San Francisco and SRI International to study the pharmacogenetics of nicotine addiction and treatment, SRI announced today.

 

SRI also announced the formation of a new molecular genetics program to analyze genetic predispositions to addiction and susceptibility for certain cancers.  

 

The long-term research objectives of the program are to "better individualize treatment for tobacco dependence, facilitate the development of novel medications, and reduce the impact of smoking as a major health problem," the organization said in a statement.

 

Principal investigators for the program are Huijun Ring of SRI and Neil Benowitz of UCSF.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.